http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2991979-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_139aff3556869a0208383f5dac575e98
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C53-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93bfa63db0ed8150aeb21387212b6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8838257a4991c02d4d74c3bb69ee3c39
publicationDate 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2991979-A1
titleOfInvention Co-crystals of lapatinib monoacid salts
abstract The present invention refers to co-crystals of monoacid salts of the pharmaceutical active ingredient named Lapatinib and to processes for the preparation thereof and medical uses.
priorityDate 2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68558672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11679357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229267175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227592211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226880115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23652897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774

Total number of triples: 48.